↓ Skip to main content

Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies

Overview of attention for article published in Frontiers in immunology, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
11 X users

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
177 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Published in
Frontiers in immunology, January 2022
DOI 10.3389/fimmu.2021.830527
Pubmed ID
Authors

Masaud Shah, Hyun Goo Woo

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 177 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 11%
Researcher 19 11%
Student > Bachelor 16 9%
Student > Master 13 7%
Student > Postgraduate 6 3%
Other 16 9%
Unknown 88 50%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 13%
Medicine and Dentistry 15 8%
Chemistry 10 6%
Immunology and Microbiology 7 4%
Agricultural and Biological Sciences 5 3%
Other 24 14%
Unknown 93 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2023.
All research outputs
#1,826,758
of 26,168,182 outputs
Outputs from Frontiers in immunology
#1,688
of 33,003 outputs
Outputs of similar age
#45,201
of 531,567 outputs
Outputs of similar age from Frontiers in immunology
#77
of 1,545 outputs
Altmetric has tracked 26,168,182 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 531,567 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 1,545 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.